Ratings Türkiye Is Bankasi Borsa Istanbul

Equities

ISBTR

TRAISBTR91N4

Delayed Borsa Istanbul Other stock markets 06:55:17 2024-07-17 am EDT			5-day change	1st Jan Change
770,000 ^TRY	+1.52%		+3.15%	+35.09%

May. 10	Türkiye Is Bankasi A.S. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
May. 10	Transcript : Türkiye Is Bankasi A.S., Q1 2024 Earnings Call, May 10, 2024

Strengths

The prospective high growth for the next fiscal years is among the main assets of the company
The earnings growth currently anticipated by analysts for the coming years is particularly strong.
The group's activity appears highly profitable thanks to its outperforming net margins.
Its low valuation, with P/E ratio at 5.08 and 2.86 for the ongoing fiscal year and 2025 respectively, makes the stock pretty attractive with regard to earnings multiples.
Over the last twelve months, the sales forecast has been frequently revised upwards.
Over the last 4 months, analysts have significantly revised upwards the company's estimated sales.
For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
For the past twelve months, EPS forecast has been revised upwards.
Historically, the company has been releasing figures that are above expectations.

Ratings chart - Surperformance

Sector: Banks

	1st Jan change	Capi.	ESG Refinitiv
TÜRKIYE IS BANKASI	+35.09%	15.38B	-
JPMORGAN CHASE & CO.	+25.58%	608B	C+
BANK OF AMERICA CORPORATION	+31.07%	343B	C+
INDUSTRIAL AND COMMERCIAL BANK OF CHINA LIMITED	+14.14%	267B	C+
WELLS FARGO & COMPANY	+22.39%	205B	C
CHINA CONSTRUCTION BANK CORPORATION	+17.42%	178B	B-
BANK OF CHINA LIMITED	+15.44%	179B	B-
HSBC HOLDINGS PLC	+4.28%	157B	C+
ROYAL BANK OF CANADA	+12.76%	156B	B-
COMMONWEALTH BANK OF AUSTRALIA	+19.41%	149B	C+

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes